The tough go shopping

A new breed of investors in mortgage-backed securities is taking advantage of the 'blood on the streets' resulting from the subprime crash and showing a big appetite for the bargains on offer. William Rhode reports

"There is an old saying: 'When there is blood in the streets, it is time to buy - even if the blood is your own.' This is certainly true in the subprime market today," says Jim Midanek, chief investment officer at California-based Black Pearl Asset Management.

Midanek, who helped build numerous Wall Street mortgage trading and sales desks in the late 1980s, is one of a select breed now looking to buy securitisations backed by subprime loans. He set up Black Pearl in 2002 with John Pak, an

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Chartis RiskTech100® 2024

The latest iteration of the Chartis RiskTech100®, a comprehensive independent study of the world’s major players in risk and compliance technology, is acknowledged as the go-to for clear, accurate analysis of the risk technology marketplace. With its…

T+1: complacency before the storm?

This paper, created by WatersTechnology in association with Gresham Technologies, outlines what the move to T+1 (next-day settlement) of broker/dealer-executed trades in the US and Canadian markets means for buy-side and sell-side firms

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here